Cite
MLA Citation
Patrizia Froesch et al.. “Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial.” Lung cancer, vol. 156, 2021, pp. 91–99. http://access.bl.uk/ark:/81055/vdc_100130253747.0x000049